Tüdőrák: vizsgálatok itt: Franciaország
316 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 17.. Ask the study team whether a trial fits you.
- No phaseTaking peopleProspective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening Pathway
- Where
- Marseille
- Életkor
- 45 év to 80 év
- People
- 750
- Run by
- Assistance Publique Hopitaux De Marseille
See details and how to joinNCT06387017 - No phaseTaking peopleEvaluation of the Contribution of a DEMaterialized VIdeo-pedagogical SUpport in the Care Pathway of Lung Cancer Surgery Patients
- Where
- Marseille
- Életkor
- 18 év and over
- People
- 226
- Run by
- Assistance Publique Hopitaux De Marseille
See details and how to joinNCT06577844 - 3. fázisFut, nem toborozA Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
- Where
- Créteil, Grenoble Cedex 9, Lille, Marseille, Montpellier, Paris, Pierre-Bénite, Quimper Cedex, Villefranche Sur Saone Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 530 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06646276 · EU 2024-515740-23-00 - 2. fázisTaking peopleA Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
- Where
- Caen, Limoges, Pessac, Rennes, Toulon
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- Wayshine Biopharm, Inc.
See details and how to joinNCT06868485 - 1/2. fázisTaking peopleA Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Where
- Lyon, Marseille, Paris
- Életkor
- 18 év and over
- People
- 616 worldwide
- Run by
- Verastem, Inc.
See details and how to joinNCT07020221 - 3. fázisTaking peopleA Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
- Where
- Boulogne-Billancourt, Grenoble, Saint-Herblain, Villejuif
- Életkor
- 18 év and over
- People
- 420 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07099898 - 3. fázisTaking peoplePhase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
- Where
- Boulogne-Billancourt, Lyon, Marseille, Saint-Herblain, Toulouse
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07291037 · EU 2024-520101-39-00 - 3. fázisTaking peopleDAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- Where
- Angers, Bordeaux, Caen Cedex 5, Dijon, Marseille, Paris, Saint-Herblain, Toulouse, Villefranche Sur Saone Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 670 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07472517 · EU 2025-520565-51-00 - 3. fázisNot yet taking people in FranciaországStudy of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
- Where
- Bron, Caen Cedex 5, Dijon, Grenoble Cedex 9, Lyon, Marseille, Paris, Quimper Cedex, Saint-Herblain, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 850 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07680790 · EU 2026-526486-21-00 - 1/2. fázisNot yet taking people in FranciaországA Study of DS-3939a in Participants With Solid Tumors
- Where
- Marseille, Montpellier, Paris, Rennes, Saint-Herblain, Suresnes, Vandœuvre-lès-Nancy, Villejuif
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT07739966 · EU 2026-525218-75-00 - 1/2. fázisNot yet taking people in FranciaországA Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)
- Where
- Lyon, Marseille, Villejuif Cedex
- Életkor
- 18 év and over
- People
- 55 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07843940 · EU 2026-525459-99-00 - 1. fázisNot yet taking people in FranciaországA Study of LY4336619 in Adult Participants With Advanced Solid Tumors
- Where
- Lyon, Saint-Herblain, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 370 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07928258 · EU 2026-526553-33-00 - No phaseTaking peopleAnalysis of Circulating Tumor Markers in Blood
- Where
- Montpellier
- Életkor
- 18 év and over
- People
- 992
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT04025541 - 3. fázisTaking peopleA Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
- Where
- Avignon, Bayonne, Bordeaux Cedex, Brest Cedex 2, Dijon, Le Mans Cedex 9, Lille, Marseille, Paris, Pierre-Bénite, Toulon, Toulouse, Vandoeuvre Les Nancy Cedex
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06561386 · EU 2024-513682-40-01 - 3. fázisTaking peopleA Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Where
- Caen, Lille, Lyon, Paris Cedex 13, Saint-Herblain Cedex, Tours, Villejuif
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06623422 · EU 2023-506327-29-00 - 1/2. fázisNot yet taking people in FranciaországA Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
- Where
- Brest, Bron, Grenoble Cedex 9, Limoges
- Életkor
- 18 év to 64 év
- People
- 170 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07227597 · EU 2025-521032-11-00 - 2. fázisTaking peopleBeamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab
- Where
- Lyon, Paris
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07486817 · EU 2025-523567-38-00 - 3. fázisNot yet taking people in FranciaországA Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
- Where
- Avignon, Bron, Caen Cedex 5, Clermont Ferrand Cedex 1, Lyon, Montpellier Cedex 5, Quimper Cedex, Reims Cedex, Saint-Herblain, Strasbourg Cedex, Suresnes, Villejuif
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07541170 · EU 2025-524263-21-01 - 3. fázisNot yet taking people in FranciaországA Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
- Where
- Avignon Cedex 9, Boulogne-Billancourt, Bron, Caen Cedex 5, Caen Cedex 9, Créteil, Dijon, Le Mans Cedex 9, Lyon, Lyon Cedex 04, Marseille, Nice Cedex 2, Paris, Pessac, Pierre-Bénite, Quimper Cedex, Rennes, Saint-Herblain, Saint-Herblain Cedex, Suresnes, Valenciennes, Villefranche Sur Saone Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 356 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07566052 · EU 2025-524079-22-00 - 1/2. fázisTaking peopleA Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Where
- Lyon, Saint-Herblain, Toulouse Cedex 9, Villejuif
- Életkor
- 12 év and over
- People
- 840 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05384626 · EU 2024-514266-39-00 - 3. fázisFut, nem toborozStudy of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- Where
- Bordeaux, Brest, Bron, Creteil Cedex, Grenoble Cedex 9, Lille, Lyon, Marseille, Montpellier Cedex 5, Paris, Paris Cedex 18, Rennes Cedex 9, Saint-Herblain, Saint-Herblain Cedex, Strasbourg Cedex, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 590 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06881784 · EU 2024-518154-16-00 - No phaseTaking peopleAnalysis of Circulating Tumor Markers in Blood - ALCINA 5
- Where
- Montpellier
- Életkor
- 18 év and over
- People
- 620
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT07060950 - No phaseTaking peopleDevelopment of Clinical and Biological Database on Bronchial Cancer
- Where
- Montpellier
- Életkor
- 18 év and over
- People
- 750
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT07085429 - 1/2. fázisNot yet taking people in FranciaországA Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
- Where
- Dijon, Marseille
- Életkor
- 18 év and over
- People
- 315 worldwide
- Run by
- Voronoi, Inc
See details and how to joinNCT07699328 · EU 2025-523122-40-00 - No phaseNot yet taking people in FranciaországPROMETHEE: A Shared Interregional Tele-Tobacco Cessation Platform Embedded Within the IMPULSION Lung Cancer Screening Program
- Where
- Pierre-Bénite
- Életkor
- 50 év to 74 év
- People
- 5400
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT07921719